DSP Healthcare Fund Regular Growth | DSP Healthcare Fund NAV Today [41.28], Performance & History

A Oneindia Venture

Get Updates

Get notified about market trends, financial advice, and investment tips!

Sensex 76,802.90 -0.78% ↓ Nifty 24,013.10 -0.64% ↓ 22k Gold ₹ 13,390/gm Silver ₹ 2,50,000/kg Petrol ₹ 111.18 Diesel ₹ 97.83 LPG ₹ 941.50 Crude Oil $ 80.38 USD ₹ 94.37

Equity Sectoral Thematic Regular

Regular

Direct

3 Year Absolute Returns

77.25% ↑

NAV (₹) on 18 Jun 2026

41.28

1 Day NAV Change

0.50%

Risk Level

Very High Risk

Rating

DSP Healthcare Fund is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment of ₹100. The ... Read more

NAV History

Fund Details

Min. SIP Amount

N/A

Inception Date

12 Nov 2018

Min. Lumpsum Amount

₹ 100

Fund Age

7 Yrs

AUM

₹ 3,309.17 Cr.

Benchmark

BSE Healthcare Total Return

Expense Ratio

1.92%

Scheme Type

Open Ended

Exit Load

0.5%

Returns Calculator

Investment amount per month

₹1,000

Over the past

Would have become

On total investment of

*Calculation based on past performance of this fund.

Asset Allocation

AUM

₹ 3,309.17 Cr

Equity

405.06%

Money Market & Cash

12.05%

Other Assets & Liabilities

83.5%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	61.44%
Foreign Securities	17.13%
Hospitals & Medical Services	12.72%
Treps/Reverse Repo	6.47%
Finance - Non Life Insurance	1.31%
International Mutual Fund Units	0.88%
Medical Equipment & Accessories	0.20%

See All

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Limited	8.79%	₹ 266.73	Pharmaceuticals
IPCA Laboratories Limited	8.55%	₹ 259.36	Pharmaceuticals
Cipla Limited	8.06%	₹ 244.49	Pharmaceuticals
Globus Medical Inc	7.69%	₹ 233.39	Others
Laurus Labs Limited	6.50%	₹ 197.15	Pharmaceuticals
Illumina Inc	6.47%	₹ 196.16	Others
Sai Life Sciences Limited	5.90%	₹ 178.91	Pharmaceuticals
Gland Pharma Limited	5.53%	₹ 167.76	Pharmaceuticals
Apollo Hospitals Enterprise Limited	5.02%	₹ 152.34	Hospitals & Medical Services
Alembic Pharmaceuticals Limited	3.35%	₹ 101.57	Pharmaceuticals
Pfizer Limited	3.35%	₹ 101.57	Pharmaceuticals
Vijaya Diagnostic Centre Limited	3.10%	₹ 93.97	Hospitals & Medical Services
Cohance Lifesciences Limited	3.04%	₹ 92.12	Pharmaceuticals
Kovai Medical Center and Hospital Limited	2.88%	₹ 87.32	Hospitals & Medical Services
Intuitive Surgical Inc	2.83%	₹ 85.95	Others
Procter & Gamble Health Limited	2.57%	₹ 78.06	Pharmaceuticals
Indoco Remedies Limited	2.16%	₹ 65.41	Pharmaceuticals
Concord Biotech Limited	2.00%	₹ 60.63	Pharmaceuticals
Emcure Pharmaceuticals Limited	1.86%	₹ 56.49	Pharmaceuticals
ICICI Lombard General Insurance Company Limited	1.51%	₹ 45.90	Finance - Non Life Insurance
Nephrocare Health Services Limited	1.24%	₹ 37.71	Hospitals & Medical Services
TREPS / Reverse Repo Investments	1.14%	₹ 34.73	Others
Abbott Laboratories	1.10%	₹ 33.44	Others
Aarti Drugs Limited	1.03%	₹ 31.27	Pharmaceuticals
Unichem Laboratories Limited	0.97%	₹ 29.50	Pharmaceuticals
Global X Funds - Global X Genomics & Biotechnology ETF	0.88%	₹ 26.55	Others
Alkem Laboratories Limited	0.69%	₹ 21.05	Pharmaceuticals
Corona Remedies Limited	0.61%	₹ 18.57	Pharmaceuticals
Medplus Health Services Limited	0.54%	₹ 16.28	Pharmaceuticals
Jupiter Life Line Hospitals Limited	0.39%	₹ 11.88	Hospitals & Medical Services
Laxmi Dental Limited	0.18%	₹ 5.40	Medical Equipment & Accessories
Grail Inc	0.14%	₹ 4.23	Others

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	3.67%	8.31%	11.13%	21.02%
Category returns	1.21%	5.68%	6.27%	22.53%

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

AMC Details

Name

DSP Investment Managers Pvt. Ltd.

Date of Incorporation

16 Dec 1996

CEO

Mr. Kalpen Parekh

CIO

Type

Pvt.Sector-Indian

Address

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai, Maharashtra, India - 400021

Website

http://www.dspblackrock.com

[email protected]

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund Sector Regular	₹29.45	17.51%	191.18%	0.00%	₹9,724	1.75%	Very High

Top Funds from DSP Investment Managers Pvt. Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
DSP World Gold Mining Overseas Equity Omni FoF - Direct Plan International/ Global Direct	₹59.18	75.43%	222.00%	210.01%	₹1,679	1.66%	Very High
DSP World Gold Mining Overseas Equity Omni FoF International/ Global Regular	₹55.01	74.27%	215.71%	199.97%	₹1,679	2.30%	Very High
DSP Silver ETF ETF Regular	₹221.72	112.59%	209.07%	0.00%	₹1,851	N/A	Very High
DSP World Gold Mining Overseas Equity Omni FoF - Direct Plan International/ Global Direct	₹35.43	75.43%	191.34%	152.85%	₹1,679	1.66%	Very High
DSP World Gold Mining Overseas Equity Omni FoF - Direct Plan International/ Global Direct	₹35.43	75.43%	191.34%	152.85%	₹1,679	1.66%	Very High
DSP World Gold Mining Overseas Equity Omni FoF International/ Global Regular	₹33.33	74.28%	186.87%	147.60%	₹1,679	2.30%	Very High
DSP World Gold Mining Overseas Equity Omni FoF International/ Global Regular	₹33.33	74.28%	186.87%	147.60%	₹1,679	2.30%	Very High
DSP Gold ETF ETF Regular	₹140.03	44.64%	137.34%	0.00%	₹2,460	N/A	High
DSP US Specific Equity Omni FoF - Direct Plan International/ Global Direct	₹102.92	52.73%	112.26%	146.41%	₹1,323	1.48%	Very High
DSP US Specific Equity Omni FoF International/ Global Regular	₹93.16	51.45%	106.98%	136.08%	₹1,323	2.32%	Very High

FAQs

What is the current NAV of DSP Healthcare Fund Regular Growth?

The current Net Asset Value (NAV) of DSP Healthcare Fund Regular Growth is ₹41.28 as of 18 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of DSP Healthcare Fund Regular Growth?

The Assets Under Management (AUM) of DSP Healthcare Fund Regular Growth is ₹3,309.17 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of DSP Healthcare Fund Regular Growth?

DSP Healthcare Fund Regular Growth has delivered returns of 8.31% (1 Year), 21.02% (3 Year), 14.19% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of DSP Healthcare Fund Regular Growth?

DSP Healthcare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for DSP Healthcare Fund Regular Growth?

The minimum lumpsum investment required for DSP Healthcare Fund Regular Growth is ₹100. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article